You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 復星醫藥(2196.HK)大漲10%創歷史新高 市值逼近1400億!
格隆匯 05-03 10:08
格隆匯5月3日丨近期市場資金青睞醫美和抗疫概念股,其中,同時屬於這兩個概念的復星醫藥(2196.HK)持續走強,現大漲9.63%,報54.1港元創歷史新高,暫成交1.98億港元,最新總市值1386億港元。復星醫藥近日公佈,截至4月30日,公司控股子公司上海復星醫藥產業發展有限公司獲BioNTech許可的用於預防新型冠狀病毒肺炎的mRNA疫苗BNT162b2已分別被使用於中國香港、中國澳門的政府接種計劃;該疫苗於中國境內尚處於II期臨牀試驗階段。此外,復星集團董事長郭廣昌昨日在個人微博上表示,將有15000台邁卓製氧機在未來陸續啟程運往印度疫情一線地區。瑞信對公司長期研發展望更趨正面,目標價由44港元上調至52港元,評級“跑贏大市”。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account